On Monday, Mankind Pharma has announced its foray into the agri-tech segment, with plans to invest up to Rs 200 crore in the first two to three years. The company has set up a new arm Mankind Agritech Pvt Ltd, which will offer various crop care solutions to Indian farmers, including weedicides, insecticides, fungicides, plant growth regulators, and biologicals Mankind Pharma said in a statement.

“We are happy to announce our launch in the agritech domain with long-term investment plans, with an initial (Rs) 150 to (Rs) 200 crore Capex infusion in the first two to three years,” Mankind Pharma Managing Director and Vice-Chairman Rajeev Juneja said. Asserting that technology is playing a crucial role in ensuring the growth of the agriculture sector in India, he said, “Agritech has the potential to scale up the agricultural industry through technological intervention. If the farmers get the right products and tools, they would be in a position to make an informed decision of using input and right technology”.

• Income Tax Refund Grew 46% in April-November 
• Inventurus Knowledge Solutions Ltd IPO GMP, Lot Size, Key Dates & Investing Details
• Swiss National Bank Cuts Interest Rate by 50 Basis Points 
• SolarSquare Secures $40 in Series B Funding Round 
• CEA Maintains 6.5-7% Growth Estimate for FY25

The new vertical will be headed by Indian agrochemical industry veteran Partha Sengupta, who was the national marketing head and part of the senior leadership team at Dhanuka Agritech Ltd, overseeing marketing operations in India, Bangladesh and Nepal, the company said.

The decision behind foraying into this division is to assist Indian farmers by providing new-age technologies and helping farmers for the betterment of the rural sector, it added.